PB Fintech Ltd

PB Fintech. Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

PB Fintech Ltd

₹ 1,794 -2.09%
11 Jul - close price
pbfintech.in BSE: 543390 NSE: POLICYBZR
About

PB Fintech Ltd, popularly known as Policy Bazar is India’s largest online platform for insurance and lending products through its flagship brands - Policybazaar and Paisabazaar platform through which they provide convenient access to insurance, credit and other financial products[1]

Key Points

Business Platforms
1) PolicyBazaar: The company’s flagship brand, Policybazaar, is India’s leading digital insurance marketplace, holding a 93% market share. It primarily caters to middle-class families in India, offering protection against death, disease, and disability through products like health, term, motor, and travel insurance, etc. As of Q2 FY25, the platform has 86.9 million registered users, and 18.3 million active users, and has sold over 46.8 million insurance policies. [1] [2] [3]

Website BSE NSE
  • Market Cap ₹ 82,382 Cr.
  • Current Price ₹ 1,794
  • High / Low ₹ 2,255 / 1,311
  • Stock P/E 1,58,426
  • Book Value ₹ 173
  • Dividend Yield 0.00 %
  • ROCE 0.01 %
  • ROE 0.01 %
  • Face Value ₹ 2.00
Edit ratios

Pros

  • Company has reduced debt.
  • Company is almost debt free.
  • Company is expected to give good quarter

Cons

  • Stock is trading at 10.4 times its book value
  • Though the company is reporting repeated profits, it is not paying out dividend
  • Company has a low return on equity of -0.23% over last 3 years.
  • Earnings include an other income of Rs.273 Cr.
  • Company's cost of borrowing seems high

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Financial Services Financial Services Financial Technology (Fintech) Financial Technology (Fintech)

Part of BSE 500 BSE 100 BSE 200 Nifty 500 BSE MidCap

Edit Columns
Loading peers table ...

Quarterly Results

Standalone Figures in Rs. Crores / View Consolidated

Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025
31 28 30 32 43 35 14 27 34 30 38 39 47
122 124 124 78 72 74 75 62 103 83 98 85 141
Operating Profit -91 -96 -94 -46 -28 -39 -61 -35 -69 -53 -60 -46 -95
OPM % -292% -336% -310% -145% -65% -110% -449% -130% -201% -176% -161% -119% -202%
52 39 52 45 59 62 64 63 63 65 68 65 74
Interest 0 0 0 0 0 0 0 0 0 0 0 0 0
Depreciation 1 1 1 1 1 1 1 1 1 1 1 1 1
Profit before tax -40 -58 -43 -2 29 22 2 27 -7 12 6 18 -21
Tax % -1% 0% 0% 0% 0% 0% 0% 0% 122% 15% 15% 23% -25%
-39 -58 -43 -2 29 22 2 27 -15 10 5 14 -16
EPS in Rs -0.87 -1.29 -0.96 -0.05 0.65 0.49 0.04 0.60 -0.33 0.22 0.12 0.30 -0.34
Raw PDF

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
50 105 79 50 61 123 103 134 110 153
161 106 122 89 89 144 513 398 314 408
Operating Profit -111 -1 -43 -39 -28 -20 -409 -264 -204 -254
OPM % -222% -1% -54% -79% -46% -16% -397% -197% -185% -166%
34 53 25 34 58 54 114 195 252 273
Interest 0 0 0 0 1 2 1 1 1 0
Depreciation 2 1 3 1 9 4 4 4 3 3
Profit before tax -80 50 -21 -6 19 27 -300 -74 44 15
Tax % 0% -51% 120% 148% 49% 30% -0% 0% 18% 10%
-79 76 -47 -16 10 19 -300 -74 36 13
EPS in Rs -22,080.56 21,063.89 -12,944.60 -4,160.53 2,563.16 833.04 -6.67 -1.65 0.80 0.29
Dividend Payout % 0% 0% 0% 0% 0% 0% 0% 0% 0% 0%
Compounded Sales Growth
10 Years: %
5 Years: 20%
3 Years: 14%
TTM: 39%
Compounded Profit Growth
10 Years: %
5 Years: 15%
3 Years: 26%
TTM: -98%
Stock Price CAGR
10 Years: %
5 Years: %
3 Years: 49%
1 Year: 23%
Return on Equity
10 Years: %
5 Years: -1%
3 Years: 0%
Last Year: 0%

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Equity Capital 0.04 0.04 0.04 0.04 0.04 0.05 90 90 90 92
Reserves 346 429 921 956 2,042 2,940 6,805 7,273 7,639 7,866
1 1 1 1 3 15 11 8 5 1
17 63 47 11 19 44 19 16 71 101
Total Liabilities 364 493 969 968 2,064 2,999 6,924 7,387 7,806 8,059
6 3 2 2 3 16 12 8 6 3
CWIP 0 0 0 0 0 0 0 0 0 0
Investments 276 380 885 659 914 1,146 2,416 3,903 4,840 5,370
82 110 82 307 1,147 1,836 4,497 3,476 2,959 2,686
Total Assets 364 493 969 968 2,064 2,999 6,924 7,387 7,806 8,059

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
-56 87 -57 -199 -13 71 -57 -5 43 -103
-248 -78 -463 231 -267 -1,283 -3,748 -180 95 316
315 0 513 0 1,050 776 3,642 -3 -3 -2
Net Cash Flow 11 9 -7 32 770 -436 -163 -188 134 210

Ratios

Standalone Figures in Rs. Crores / View Consolidated

Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Debtor Days 193 106 127 30 46 35 20 2 6 2
Inventory Days
Days Payable
Cash Conversion Cycle 193 106 127 30 46 35 20 2 6 2
Working Capital Days 247 -16 -22 524 258 57 4,269 4,301 7,270 3,254
ROCE % 7% -6% -4% -1% 0% -6% -1% 1% 0%

Shareholding Pattern

Numbers in percentages

11 Recently
Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025
19.73% 17.91% 47.99% 50.41% 49.60% 49.40% 46.00% 48.97% 51.58% 49.70% 47.78% 45.93%
8.08% 9.97% 14.90% 13.97% 15.33% 16.31% 18.97% 16.64% 16.17% 18.31% 20.57% 22.95%
71.11% 71.04% 36.27% 34.79% 34.24% 33.46% 34.28% 33.81% 31.69% 31.44% 31.35% 30.85%
1.08% 1.07% 0.83% 0.83% 0.83% 0.83% 0.76% 0.59% 0.55% 0.54% 0.28% 0.28%
No. of Shareholders 1,99,3192,04,3292,13,8231,95,6721,91,7041,80,7651,65,9331,52,1531,45,3831,52,9481,48,2751,51,205

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

DRHP

Concalls